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Background: Therapeutic neovascularization is a promising treatment for chronic cardiovascular ischemia. Vascular endothelial growth factor 
(VEGF) increases capillary density but less consistently collateralization. Animal models suggest the combined actions of platelet derived growth 
factor (PDGF) and VEGF may be necessary for collateralization. We hypothesized that VEGF and PDGF would correlate with the presence of collaterals 
in humans with ischemic cardiomyopathy.
Methods: Serum VEGF, PDGF, and presence of collaterals on coronary angiography were assessed in 29 patients with ischemic cardiomyopathy and 
heart failure (HF) enrolled in an outpatient HF registry. Patients were divided into tertiles according to VEGF and PDGF.
Results: The study group (N=29) was 63±10 years, 86% male, with mean LV ejection fraction of 0.33±0.13. Most had symptomatic HF (93% 
≥NYHA II). Mean VEGF (pg/mL±SD) by tertile was 48.0±36.4, 119.0±12.9, 296.0±184.1. Mean PDGF (ng/mL±SD) by tertile was 13.6±4.4, 
25.8±4.5, 45.9±12.9. Individually, growth factors were not associated with collateralization. A strong trend was seen between VEGF and PDGF with 
collaterals more likely in patients in the highest tertile of both growth factors.
Conclusion:  Concordantly increased VEGF and PDGF are associated with coronary collateralization in patients with ischemic cardiomyopathy. 
These findings may indicate an additive or synergistic role for these growth factors in the development of coronary collateralization. 
